Standard BioTools Inc. Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31)
Standard BioTools Inc. (LAB) reported Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) of $15.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-12.
Discontinued › Notes › Receivables
us-gaap:AllowanceForDoubtfulAccountsReceivableChargeOffs · last filed 2013-03-12
- Standard BioTools Inc. allowance for doubtful accounts receivable, charge-offs (deprecated 2013-01-31) for fiscal 2012 was $15.00K, a 86.73% decline from fiscal 2011.
- Standard BioTools Inc. allowance for doubtful accounts receivable, charge-offs (deprecated 2013-01-31) for fiscal 2011 was $113.00K.
| Period end | Allowance for Doubtful Accounts Receivable, Charge-offs (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-12-31 | $15.00K 10-K · filed 2013-03-12 |
| 2011-12-31 | $113.00K 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |